NCT06065228Recruiting
Therapeutic Endpoint in Pediatric IBD Conditions
Development of a Therapeutic Endpoint in Pediatric IBD Conditions
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 27 Sept 2023
- Start date
- 27 Nov 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Children's National Research Institute
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06065228
What you commit to
- Study type: Observational
- Planned participants: 60
- From 27 Nov 2023 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Documented history of eye disease precluding pupillometry
Other
- Patients who are unwilling or unable to participate due to developmental delays or ongoing psychological diagnoses.
Who the study is looking for
- Male or female ≥ 6 years of age at screening.
- Documentation of an IBD diagnosis as evidenced by history
Age in the registry: 6 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's National Health System Coordinator of this site? Confirm its status | Washington D.C. | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.